News about Global Pharma

Malaysian Government Extends Insulin Supply Contract with Biocon Biologics

The Malaysian Health Ministry has extended the contract with Biocon Biologics to continue insulin supply under the partnership with Duopharma and Biocon Sdn. Bhd.

Global Pharma | 23/05/2025 | By Manvi |  359

Bayer Gets Regulatory Approval of Aflibercept 8 MG in China

China gives approval to Bayer over the Application for Regulatory Approval of Aflibercept 8 MG used for the treatment of neovascular (wet) age-related macular degeneration (nAMD).

Global Pharma | 23/05/2025 | By Manvi |  466

Ecolab Life Sciences Opens New Bioprocessing Applications Laboratory in US

Ecolab’s new bioprocessing applications laboratory in the US will support biopharma and CDMOs with bioprocessing applications and purification development.

Global Pharma | 23/05/2025 | By Manvi |  450

Celltrion's YUFLYMA Secures FDA Interchangeability Designation

Celltrion has announced that the FDA has granted expanded interchangeable designation to YUFLYMA (adalimumab-aaty), now covering prefilled syringe (40mg) and autoinjectors (40mg and 80mg) presentations, making it fully interchangeable with Humira.

Global Pharma | 23/05/2025 | By Manvi |  270

Pfizer Enters into Exclusive Licensing Agreement with 3SBio

Pfizer and Chinese biopharmaceutical company 3SBio have entered into a licensing agreement valued at approximately USD 6 billion for the development, manufacturing, and commercialisation of SSGJ-707, a drug candidate targeting various cancers.

Global Pharma | 22/05/2025 | By Manvi |  462

Lilly's Kisunla (donanemab) Secures Marketing Authorisation in Australia for Treatment of Early Symptomatic Alzheimer's Disease

Eli Lilly’s Kisunla (donanemab) has received marketing authorisation from Australia’s Therapeutic Goods Administration (TGA), becoming the country’s first approved amyloid-targeting treatment for early Alzheimer’s disease.

Global Pharma | 22/05/2025 | By Manvi |  204

Tampa General Elevates Heart Care with AI-Powered 512-Slice CT Scanners from GE Healthcare

The advanced scanners leverage artificial intelligence (AI) and machine learning technologies to deliver faster, clearer and more precise scans, refining diagnoses and treatments of cardiovascular diseases.

Global Pharma | 22/05/2025 | By Manvi |  301

OMRON Launches AI-Enabled BP Monitors with Built-In AFib Detection

OMRON Healthcare introduced home blood pressure monitors with built-in AI-powered detection of atrial fibrillation.

Global Pharma | 22/05/2025 | By Manvi |  654

SK Bioscience Prevails in Patent Dispute Against Pfizer Over Pneumococcal Vaccine

SK bioscience has won a major patent lawsuit filed by Pfizer, with the Supreme Court of Korea ruling that SK's pneumococcal vaccine exports did not infringe on Pfizer’s Prevnar 13 patent, clearing the way for renewed global business expansion.

Global Pharma | 22/05/2025 | By Manvi |  389

TheraLight Launches 360i System with PBM, PEMF, and ART Therapies

TheraLight, LLC announces the launch of the TheraLight 360i, a next-generation whole body therapy system that uniquely integrates three advanced, non-invasive therapeutic modalities: Photobiomodulation (PBM), Pulsed Electromagnetic Field (PEMF) Therapy, and Acoustic Resonance Therapy (ART).

Global Pharma | 21/05/2025 | By Manvi |  405